Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Completed1
Recruiting1
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06442423Phase 1Recruiting
Open-Label Psilocybin Study in Transdiagnostic Population
AnxietyDepression - Major Depressive DisorderOCD+5 more
PrincipalinvestigatorStart date: 2024-10-17
NCT05370911Phase 1Active Not Recruiting
Effects of Repeated Psilocybin Dosing in OCD
Obsessive-Compulsive Disorder
PrincipalinvestigatorStart date: 2023-07-20
NCT03356483Phase 1Completed
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Obsessive-Compulsive Disorder
PrincipalinvestigatorStart date: 2018-11-13
NCT03752918Phase 1Withdrawn
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
Post Traumatic Stress Disorder
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Gabrielle Agin-Liebes, PhD

Yale University

Very Similar
1 trials

Shared therapeutic areas:

AnxietyDepression - Major Depressive DisorderOCD+5 more

Worked with same sponsors:

Usona InstituteYale University
Collaborated on 1 trial
Similarity Score84%

Terence Ching, PhD

Yale University

Related
1 trials

Shared therapeutic areas:

Obsessive-Compulsive Disorder

Worked with same sponsors:

Steven & Alexandra Cohen FoundationYale University
Collaborated on 1 trial
Similarity Score14%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

AnxietyStress Disorders, Post-TraumaticSubstance Use+1 more
Similarity Score13%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Stress Disorders, Post-TraumaticObsessive-Compulsive DisorderOCD
Similarity Score10%

Yair bAR-hAIM, PhD

Tel Aviv University

Related
18 trials

Shared therapeutic areas:

Stress Disorders, Post-TraumaticAnxiety
Similarity Score7%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

AnxietyObsessive-Compulsive Disorder
Similarity Score7%

Gerhard Andersson, pHD

Linkoeping University

Related
12 trials

Shared therapeutic areas:

AnxietyDepression - Major Depressive Disorder
Similarity Score7%

Joseph Zohar, MD

Tel Aviv University

Related
12 trials

Shared therapeutic areas:

Obsessive-Compulsive DisorderStress Disorders, Post-Traumatic
Similarity Score7%

Hesheng Liu, Ph.D.

Changping Laboratory

Related
20 trials

Shared therapeutic areas:

Obsessive-Compulsive DisorderOCD
Similarity Score7%

Dorota Sys, PhD

Centre of Postgraduate Medical Education

Related
4 trials

Shared therapeutic areas:

Anxiety
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06442423Phase 1PrincipalInvestigator

Open-Label Psilocybin Study in Transdiagnostic Population

AnxietyDepression - Major Depressive DisorderOCD+5 more
Recruiting
NCT05370911Phase 1PrincipalInvestigator

Effects of Repeated Psilocybin Dosing in OCD

Obsessive-Compulsive Disorder
Active Not Recruiting
NCT03356483Phase 1PrincipalInvestigator

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Obsessive-Compulsive Disorder
Completed
NCT03752918Phase 1PrincipalInvestigator

The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.

Post Traumatic Stress Disorder
Withdrawn

All 4 trials loaded